Cargando…
Efficacy and tolerability of adjunctive perampanel treatment in children under 12 years of age with refractory epilepsy
PURPOSE: There is limited data on the use of perampanel in children under 12 years of age. We evaluated the efficacy and tolerability of adjunctive perampanel treatment in children under 12 years of age with refractory epilepsy. METHODS: This retrospective observational study was performed in Kyungp...
Autores principales: | Yun, Yuni, Kim, Dongsub, Lee, Yun-Jeong, Kwon, Soonhak, Hwang, Su-Kyeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Pediatric Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642925/ https://www.ncbi.nlm.nih.gov/pubmed/30590000 http://dx.doi.org/10.3345/kjp.2018.06863 |
Ejemplares similares
-
Real-Life Effectiveness and Tolerability of Perampanel in Pediatric Patients Aged 4 Years or Older with Epilepsy: A Korean National Multicenter Study
por: Hwang, Su-Kyeong, et al.
Publicado: (2020) -
Effectiveness and tolerability of adjunctive perampanel in pediatric patients (aged 4–12 years) with refractory epilepsy: An observational study
por: Chu, Si-Jia, et al.
Publicado: (2022) -
Efficacy of perampanel as an adjunctive therapy in pediatric focal epilepsy
por: Zhang, Wei-Ran, et al.
Publicado: (2023) -
Adjunctive perampanel for glioma-associated epilepsy()
por: Dunn-Pirio, Anastasie M., et al.
Publicado: (2018) -
Perampanel is also a useful adjunctive treatment option in refractory epilepsy in children
por: Kim, Jon Soo, et al.
Publicado: (2019)